

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Dehydrogenase ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trilostane | ✔ | 99+% | |||||||||||||||||
| AGI-6780 |
+++
IDH2 R140Q mutant, IC50: 23 nM |
99%+ | |||||||||||||||||
| Gimeracil | ✔ | 98% | |||||||||||||||||
| AGI-5198 |
++
R132C-IDH1, IC50: 0.16 μM R132H-IDH1, IC50: 70 nM |
99%+ | |||||||||||||||||
| SW033291 |
++++
15-PGDH, IC50: 1.5 nM 15-PGDH, Ki: 0.1 nM |
99%+ | |||||||||||||||||
| Mycophenolic acid | ✔ | 99+% | |||||||||||||||||
| Fomepizole | ✔ | 98% | |||||||||||||||||
| Leflunomide | ✔ | 98% | |||||||||||||||||
| 3-Nitropropanoic acid | ✔ | 99%+ | |||||||||||||||||
| Isovaleramide | ✔ | 99% | |||||||||||||||||
| Mycophenolate Mofetil |
+++
Inosine monophosphate dehydrogenase II, IC50: 27 nM Inosine monophosphate dehydrogenase I, IC50: 39 nM |
98% | |||||||||||||||||
| MK-8245 |
++++
SCD1 (mouse), IC50: 1 nM SCD1 (rat), IC50: 3 nM |
99%+ | |||||||||||||||||
| Vidofludimus |
++
Human DHODH, IC50: 134 nM |
99%+ | |||||||||||||||||
| Emodin | ✔ | 98% | |||||||||||||||||
| Ivosidenib | ✔ | 98% | |||||||||||||||||
| NCT-501 |
++
ALDH1A1, IC50: 40 nM |
98% | |||||||||||||||||
| Gossypol | ✔ | 99%+ | |||||||||||||||||
| Devimistat | ✔ | 98% | |||||||||||||||||
| Disulfiram | ✔ | 98%+ | |||||||||||||||||
| Enasidenib |
++++
IDH2, IC50: 12 nM |
98% | |||||||||||||||||
| PluriSIn 1 | ✔ | 99%+ | |||||||||||||||||
| ML390 |
+
DHODH, IC50: 0.56 μM |
99%+ | |||||||||||||||||
| Teriflunomide | ✔ | 99%+ | |||||||||||||||||
| Daidzin |
+++
ALDH-Ⅰ, Ki: 20 nM |
98+% | |||||||||||||||||
| 18β-Glycyrrhetinic acid | ✔ | 99% | |||||||||||||||||
| RRx-001 | ✔ | 95% | |||||||||||||||||
| NCT-503 |
+
PHGDH, IC50: 2.5 μM |
99%+ | |||||||||||||||||
| Vorasidenib | ✔ | 99%+ | |||||||||||||||||
| Ammonium Glycyrrhizinate(x:1) | ✔ | 98+% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | DHODH-IN-17, a 2-anilino nicotinic acid derivative, acts as an inhibitor of human DHODH with an IC50 of 0.40 µM. It is suitable for research on acute myeloid leukemia (AML)[1]. |
| 体外研究 | DHODH-IN-17, a compound of 2-anilino nicotinic acid, inhibits human DHODH, demonstrating an IC50 of 0.40 µM[1]. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
4.02mL 0.80mL 0.40mL |
20.11mL 4.02mL 2.01mL |
40.21mL 8.04mL 4.02mL |
|
| CAS号 | 16344-26-6 |
| 分子式 | C12H9ClN2O2 |
| 分子量 | 248.67 |
| SMILES Code | O=C(C1=CC=CN=C1NC2=CC=C(Cl)C=C2)O |
| MDL No. | MFCD03114306 |
| 别名 | |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 85 mg/mL(341.83 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1